Singapore healthcare firm Basel Medical Group Ltd said it has entered into exclusive negotiations to buy $1 billion of Bitcoin (BTC). It’s a strategic step to build its Bitcoin treasury and drive growth in Asia’s booming healthcare sector.
According to a press release, the company is working with a group of institutional investors and wealthy individuals from the crypto world to complete this deal through an innovative share-swap arrangement. If finalized, this would mark one of the largest Bitcoin acquisitions by a healthcare company in the Asia-Pacific region.
BMGL will use this capital injection to create one of the healthiest financial positions among Asia-focused healthcare providers. The purchase of Bitcoin is not so much about investing in cryptocurrency, it’s part of a wider financing high-growth markets.
CEO Dr. Darren Chhoa highlighted that the move would give BMGL the financial muscle needed to act quickly on new opportunities while keeping its core medical business strong and well-managed.
Basel Medical Group is known for its orthopedic, trauma, sports medicine, and neurosurgical services, with over 20 years of experience in Singapore. It has strong ties with major industries like construction, marine, and oil & gas, and is now aiming to expand further in Southeast Asia, where rising income levels, aging populations, and increased healthcare demand are driving private sector growth.
The firm anticipates completing the transaction during the present quarter, subject to customary closing conditions and regulatory clearances. This daring step represents an emerging trend of conventional businesses venturing into crypto assets as a component of their fiscal strategy to enhance robustness and growth prospects.
Also Read: Corporate Bitcoin Buying Hits $16B, Outpaces ETFs and Retail
